Bloomberg 創科快訊 — Innotech Insights

Alphabet旗下的人工智能(AI)公司DeepMind在兩年一度的生物學會議上顛覆以往製藥商研發新藥的技術和方法。它還可能為世界上最大的製藥公司帶來壓力，使其為科技軍備競賽做好準備。同時，新一代新興企業已經開始加入這場激烈競爭。

"DeepMind, the artificial-intelligence arm of Google’s parent Alphabet Inc., reported in a biennial biology conference about the novel intrusive method to develop fabrication and synthetic technologies for pharmaceutical drugs. The new findings exerted immense pressure on the world’s largest pharmaceutical companies and will inevitably enforce them to enter into a new phase of technological competition. A new breed of upstarts has already jumped into the fray."

(Bloomberg, 2019)

Press HERE for the article